featured
Reasons for Discontinuation of Dupilumab in Adult Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice
Br J Dermatol 2021 Nov 08;[EPub Ahead of Print], ME Marniquet, J Seneschal, AS Darrigade, D Staumont-Sallé, M Jachiet, A Nosbaum, M Tauber, C Abasq, MC Ferrier Le Bouedec, C Droitcourt, H Aubert, C Bernier, A Soria, N Raison-Peyron, F Tétart, F Aubin, M Viguier, A Valois, I Kupfer-Bessaguet, T Goronflot, S BarbarotFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.